Suppr超能文献

鉴定永生化骨髓红系祖细胞成人(imBMEP-A)——首个从骨髓 CD71 阳性细胞中诱导产生的永生化红系祖细胞系。

Characterization of immortalized bone marrow erythroid progenitor adult (imBMEP-A)-The first inducible immortalized red blood cell progenitor cell line derived from bone marrow CD71-positive cells.

机构信息

Laboratory for Experimental Transfusion Medicine, Transfusion Medicine, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; German Red Cross Blood Donation Service North-East, Institute for Transfusion Medicine, Dresden, Germany.

UCC, Medical Systems Biology - Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

出版信息

Cytotherapy. 2024 Nov;26(11):1362-1373. doi: 10.1016/j.jcyt.2024.06.009. Epub 2024 Jul 2.

Abstract

BACKGROUND AIMS

Ex vivo production of red blood cells (RBCs) represents a promising alternative for transfusion medicine. Several strategies have been described to generate erythroid cell lines from different sources, including embryonic, induced pluripotent, and hematopoietic stem cells. All these approaches have in common that they require elaborate differentiation cultures whereas the yield of enucleated RBCs is inefficient.

METHODS

We generated a human immortalized adult erythroid progenitor cell line derived from bone marrow CD71-positive erythroid progenitor cells (immortalized bone marrow erythroid progenitor adult, or imBMEP-A) by an inducible expression system, to shorten differentiation culture necessary for terminal erythroid differentiation. It is the first erythroid cell line that is generated from direct reticulocyte progenitors and demonstrates robust hemoglobin production in the immortalized state.

RESULTS

Morphologic analysis of the immortalized cells showed that the preferred cell type of the imBMEP-A line corresponds to hemoglobin-producing basophilic erythroblasts. In addition, we were able to generate a stable cell line from a single cell clone with the triple knockout of RhAG, RhDCE and KELL. After removal of doxycycline, part of the cells differentiated into normoblasts and reticulocytes within 5-7 days.

CONCLUSIONS

Our results demonstrate that the imBMEP-A cell line can serve as a stable and straightforward modifiable platform for RBC engineering in the future.

摘要

背景目的

体外生产红细胞(RBC)代表了输血医学的一种很有前途的替代方法。已经描述了几种从不同来源(包括胚胎、诱导多能性和造血干细胞)生成红细胞系的策略。所有这些方法都有一个共同点,即它们都需要精心设计的分化培养,而去核 RBC 的产量效率不高。

方法

我们通过诱导表达系统生成了一种源自骨髓 CD71 阳性红系祖细胞的人永生化成体红系祖细胞系(永生化骨髓红系祖细胞成体,或 imBMEP-A),以缩短终末红系分化所需的分化培养。这是第一个从直接网织红细胞祖细胞生成的红细胞系,并在永生化状态下表现出强大的血红蛋白生成能力。

结果

对永生化细胞的形态分析表明,imBMEP-A 系的首选细胞类型对应于产生血红蛋白的嗜碱性成红细胞。此外,我们能够从 RhAG、RhDCE 和 KELL 三重敲除的单个细胞克隆中生成稳定的细胞系。去除多西环素后,部分细胞在 5-7 天内分化为正成红细胞和网织红细胞。

结论

我们的结果表明,imBMEP-A 细胞系可作为未来 RBC 工程的稳定且易于修改的平台。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验